{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T20:34:48Z","timestamp":1783715688281,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Insulet France SAS"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s13300-024-01682-8","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T07:39:24Z","timestamp":1735025964000},"page":"289-306","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Experience of People with Diabetes Treated with Insulin Delivery Systems in France: A Comparative Analysis of Multiple Daily Injections, Tubeless Pumps, Tubed Pumps, and Hybrid Closed Loops"],"prefix":"10.1007","volume":"16","author":[{"given":"Jacques","family":"Beltrand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4378-0468","authenticated-orcid":false,"given":"Pierre-Yves","family":"Benhamou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Choleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Braithwaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Bonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Riveline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,24]]},"reference":[{"key":"1682_CR1","doi-asserted-by":"crossref","unstructured":"Home P. The evolution of insulin therapy. Diabetes Research and Clinical Practice [Internet]. 2021;175:108816. https:\/\/www.diabetesresearchclinicalpractice.com\/article\/S0168-8227(21)00175-3\/fulltext. Accessed 2023 Sep 6.","DOI":"10.1016\/j.diabres.2021.108816"},{"issue":"3","key":"1682_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1177\/193229681000400302","volume":"4","author":"JL Selam","year":"2010","unstructured":"Selam JL. Evolution of diabetes insulin delivery devices. J Diabetes Sci Technol. 2010;4(3):505\u201313.","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"1682_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/1932296818786513","volume":"13","author":"BH Ginsberg","year":"2019","unstructured":"Ginsberg BH. Patch pumps for insulin. J Diabetes Sci Technol. 2019;13(1):27\u201333.","journal-title":"J Diabetes Sci Technol"},{"issue":"12","key":"1682_CR4","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1007\/s13300-021-01160-5","volume":"12","author":"A Janez","year":"2021","unstructured":"Janez A, Battelino T, Klupa T, et al. Hybrid closed-loop systems for the treatment of type\u00a01 diabetes: a collaborative, expert group position statement for clinical use in central and Eastern Europe. Diabetes Ther. 2021;12(12):3107\u201335.","journal-title":"Diabetes Ther"},{"issue":"5","key":"1682_CR5","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00125-021-05391-w","volume":"64","author":"CK Boughton","year":"2021","unstructured":"Boughton CK, Hovorka R. New closed-loop insulin systems. Diabetologia. 2021;64(5):1007\u201315.","journal-title":"Diabetologia"},{"issue":"1","key":"1682_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14944","volume":"40","author":"J Speight","year":"2023","unstructured":"Speight J, Choudhary P, Wilmot EG, et al. Impact of glycaemic technologies on quality of life and related outcomes in adults with type\u00a01 diabetes: a narrative review. Diabet Med. 2023;40(1):e14944.","journal-title":"Diabet Med"},{"issue":"1","key":"1682_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.arcped.2021.10.001","volume":"29","author":"E Nivet","year":"2022","unstructured":"Nivet E, Lo G, Nivot-Adamiak S, Guitteny MA, De Kerdanet M. Impact of OMNIPOD\u00ae on the quality of life of adolescents with type\u00a01 diabetes. Arch Pediatr. 2022;29(1):21\u20136.","journal-title":"Arch Pediatr"},{"issue":"20","key":"1682_CR8","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA. 2013;310(20):2191\u20134.","journal-title":"JAMA"},{"issue":"1","key":"1682_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2337\/diacare.28.1.53","volume":"28","author":"M Peyrot","year":"2005","unstructured":"Peyrot M, Rubin RR. Validity and reliability of an instrument for assessing health-related quality of life and treatment preferences: the Insulin Delivery System Rating Questionnaire. Diabetes Care. 2005;28(1):53\u20138.","journal-title":"Diabetes Care"},{"issue":"12","key":"1682_CR10","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1007\/s00125-021-05568-3","volume":"64","author":"RIG Holt","year":"2021","unstructured":"Holt RIG, DeVries JH, Hess-Fischl A, et al. The management of type\u00a01 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2021;64(12):2609\u201352.","journal-title":"Diabetologia"},{"issue":"1","key":"1682_CR11","first-page":"S111","volume":"46","author":"NA ElSayed","year":"2022","unstructured":"ElSayed NA, Aleppo G, Aroda VR, et al. 7. Diabetes technology: standards of care in diabetes\u20142023. Diabetes Care. 2022;46(1):S111-27.","journal-title":"Diabetes Care"},{"issue":"174","key":"1682_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.108735","volume":"1","author":"AL Carlson","year":"2021","unstructured":"Carlson AL, Huyett LM, Jantz J, Chang A, Vienneau T, Ly TT. Improved glycemic control in 3,592 adults with type\u00a02 diabetes mellitus initiating a tubeless insulin management system. Diabetes Res Clin Pract. 2021;1(174):108735.","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"1682_CR13","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1177\/1932296819868698","volume":"13","author":"JE Layne","year":"2019","unstructured":"Layne JE, Huyett LM, Ly TT. Glycemic control and factors impacting treatment choice in tubeless insulin pump users: a survey of the T1D exchange glu online community. J Diabetes Sci Technol. 2019;13(6):1180\u20131.","journal-title":"J Diabetes Sci Technol"},{"issue":"12","key":"1682_CR14","first-page":"1715","volume":"19","author":"S Kamann","year":"2021","unstructured":"Kamann S, Wagner N, Oppel E. Modern diabetes devices for continuous blood sugar measuring: Limitations due to contact allergies. J Dtsch Dermatol Ges. 2021;19(12):1715\u201321.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"10","key":"1682_CR15","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1089\/dia.2019.0509","volume":"22","author":"LH Messer","year":"2020","unstructured":"Messer LH, Tanenbaum ML, Cook PF, et al. Cost, hassle, and on-body experience: barriers to diabetes device use in adolescents and potential intervention targets. Diabetes Technol Ther. 2020;22(10):760\u20137.","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"1682_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1089\/dia.2022.0513","volume":"25","author":"M Diedisheim","year":"2023","unstructured":"Diedisheim M, Pecquet C, Julla JB, et al. Prevalence and description of the skin reactions associated with adhesives in diabetes technology devices in an adult population: results of the CUTADIAB study. Diabetes Technol Ther. 2023;25(4):279\u201386.","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"1682_CR17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/1932296819897976","volume":"14","author":"ML Manning","year":"2020","unstructured":"Manning ML, Singh H, Stoner K, Habif S. The development and psychometric validation of the diabetes impact and device satisfaction scale for individuals with type\u00a01 diabetes. J Diabetes Sci Technol. 2020;14(2):309\u201317.","journal-title":"J Diabetes Sci Technol"},{"issue":"2","key":"1682_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/edn.246","volume":"11","author":"T Saarinen","year":"2014","unstructured":"Saarinen T, Fernstr\u00f6m L, Brorsson AL, Olinder AL. Insulin pump therapy is perceived as liberating, but to many it can imply a sense of the diabetes made visible. Eur Diabetes Nurs. 2014;11(2):38\u201342.","journal-title":"Eur Diabetes Nurs"},{"issue":"10","key":"1682_CR19","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/dme.13406","volume":"34","author":"C Farrington","year":"2017","unstructured":"Farrington C, Stewart ZA, Barnard K, Hovorka R, Murphy HR. Experiences of closed-loop insulin delivery among pregnant women with type\u00a01 diabetes. Diabet Med. 2017;34(10):1461\u20139.","journal-title":"Diabet Med"},{"issue":"4","key":"1682_CR20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.21037\/tp.2017.10.04","volume":"6","author":"RS Tareen","year":"2017","unstructured":"Tareen RS, Tareen K. Psychosocial aspects of diabetes management: dilemma of diabetes distress. Transl Pediatr. 2017;6(4):383.","journal-title":"Transl Pediatr"},{"issue":"75","key":"1682_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.neubiorev.2017.01.039","volume":"1","author":"S Lautenbacher","year":"2017","unstructured":"Lautenbacher S, Peters JH, Heesen M, Scheel J, Kunz M. Age changes in pain perception: a systematic-review and meta-analysis of age effects on pain and tolerance thresholds. Neurosci Biobehav Rev. 2017;1(75):104\u201313.","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"1682_CR22","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.mmm.2024.04.002","volume":"18","author":"\u00c9 Renard","year":"2024","unstructured":"Renard \u00c9, Tubiana-Rufi N, Chaillous L, et al. Actualisation de la prise de position des experts fran\u00e7ais sur l\u2019insulinoth\u00e9rapie automatis\u00e9e en boucle ferm\u00e9e. M\u00e9d des Maladies M\u00e9taboliques. 2024;18(4):343\u201393.","journal-title":"M\u00e9d des Maladies M\u00e9taboliques"},{"key":"1682_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2022.109858","volume":"187","author":"B Kulzer","year":"2022","unstructured":"Kulzer B, Freckmann G, Heinemann L, Schnell O, Hinzmann R, Ziegler R. Patch pumps: what are the advantages for people with diabetes? Diabetes Res Clin Pract. 2022;187:109858.","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-024-01682-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-024-01682-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-024-01682-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T09:20:18Z","timestamp":1738660818000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-024-01682-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1682"],"URL":"https:\/\/doi.org\/10.1007\/s13300-024-01682-8","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,24]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jacques Beltrand has received speaker Honoraria from Abbott, Medtronic, Lilly, Sanofi Winthrop, Ypsomed, Merckx and Novo Nordisk and served on advisory board panels for Sanofi Winthrop, Medtronic, Insulet and Lilly. Pierre-Yves Benhamou. has received speaker honoraria from Abbott, Eli Lilly, Novo Nordisk and Sanofi, is chief medical officer for Diabeloop, and served on advisory board panels for Abbott, Dexcom, Insulet, LifeScan, Eli Lilly, Pharmasens, Novo Nordisk and Sanofi. Carine Choleau has no conflict of interest to declare. Ben Braithwaite has no conflict of interest to declare. Alice Bonin is an employee of Insulet France SAS. Jean-Pierre Riveline is an advisory panel member for Sanofi, MSD, Eli Lilly, Novo Nordisk, AstraZeneca, Abbott, Dexcom, Alphadiab, and Medtronic, and has received research funding and provided research support to Abbott, Air Liquide, Sanofi, and Novo Nordisk.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was not subject to approval from a regulatory ethics committee, in accordance with article R1121-1 of the French Public Health Code. However, the questionnaire was reviewed by a French scientific committee of diabetes specialists. All procedures in this study complied with the laws and regulations regarding the management of personal information applicable in France, as well as the European General Data Protection Regulation. The study was conducted in accordance with the Guidelines for Good Pharmacoepidemiology Practices and the Declaration of Helsinki [].","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all users (person with diabetes or their legal guardian, as appropriate) in the form of a non-opposition statement before showing the questionnaire, as required by article R1121-1 of the French Public Health Code. The information notice also stated that the overall results of the survey, which will be fully anonymized, will be available on the partners\u2019 websites.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}